Diabetic Ketoacidosis Treatments

Find Diabetic Ketoacidosis Treatments

Brand Name

Levemir

Generic Name

Detemir

View Brand Information

FDA approval date: March 27, 2006

Classification: Insulin Analog

Form: Injection

What is Levemir (Detemir)?

LEVEMIR is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use LEVEMIR is not recommended for the treatment of diabetic ketoacidosis. LEVEMIR is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus . Limitations of Use: Not recommended for the treatment of diabetic ketoacidosis.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

EFFectiveness of Once-weekly Insulin ICodec Versus Once-daily Basal Insulin Analogues in an Insulin-naïve Type 2 diabEtes Population in Real-world cliNical pracTice- The EFFICIENT Pragmatic Study Effectiveness of Insulin Icodec in Real-world Clinical Practice

Enrollment Status: Recruiting

Publish Date: June 05, 2026

Intervention Type: Drug

Study Phase: Phase 4

Summary: This study compares insulin icodec, taken once a week, with other basal insulins, taken once a day, in people with type 2 diabetes.The purpose of this study is to see how well the approved injectable weekly insulin icodec maintains blood sugar levels when compared to approved and available daily injectable basal insulins in people with type 2 diabetes. The participants will either be prescribed we...

Randomized Controlled Trial of Glargine Versus Neutral Protamine Hagedorn Insulin for the Treatment of Diabetes Mellitus in Pregnancy

Enrollment Status: Recruiting

Publish Date: October 01, 2024

Intervention Type: Drug

Study Phase: Phase 3

Summary: We are asking you to take part in this research study because you are diagnosed with pregestational Type 2 Diabetes Mellitus or Gestational Diabetes Mellitus requiring insulin therapy in pregnancy. Currently, many hospitals differ among use of insulin for management of DM in pregnancy, with NPH, glargine and detemir being the most commonly used forms of basal insulin. Outside of pregnancy, NPH is ...

A Phase 2 Open Label Randomized Controlled Trial Determir Vs Neutral Protamine Hagedorn (NPH) In Pregnant Women: DETERMINE Study

Who is this study for: Pregnant Women

Enrollment Status: Recruiting

Publish Date: September 26, 2023

Intervention Type: Drug

Study Drugs: Insulin Detemir, Insulin Neutral Protamine Hagedorn

Study Phase: Phase 2

Summary: The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.

View All Clinical Trials